Viral Clearance Integration (Session IV): General Trends, Bracketing, QbD, Virus Preparation Quality Attributes

References

1. 1.↵
   1. Miesegaes G.,
   2. Bailey M.,
   3. Willkommen H.,
   4. Chen Q.,
   5. Roush D.,
   6. Blümel J.,
   7. Brorson K.

   Proceedings of the 2009 Viral Clearance Symposium. Dev. Biol. (Basel) 2010, 133, 3–101.

   OpenUrlPubMed
2. 2.↵
   PDA Technical Report 47. Preparation of Virus Spikes Used for Virus Clearance Studies. Parenteral Drug Association, Bethesda, MD, 2010.
3. 3.↵
   1. Miesegaes G.,
   2. Lute S.,
   3. Dement-Brown J.,
   4. Kaushal S.,
   5. Strauss D.,
   6. Chen D.,
   7. Brorson K.

   A survey of quality attributes of virus spike preparations used in clearance studies. PDA J. Pharm Sci. Technol. 2012, 66 (5), 420–433.

   OpenUrlAbstract/FREE Full Text
4. 4.↵
   ASTM. E2888–12: Standard Practice for Process for Inactivation of Rodent Retrovirus by pH. ASTM International: West Conshohocken, PA, 2012.
5. 5.↵
   1. Brorson K.,
   2. Krejci S.,
   3. Lee K.,
   4. Hamilton E.,
   5. Stein K.,
   6. Xu Y.

   Bracketed generic inactivation of rodent retroviruses by low pH treatment for monoclonal antibodies and recombinant proteins. Biotechnol. Bioeng. 2003, 82 (3), 321–329.

   OpenUrlCrossRefPubMed
6. 6.↵
   1. Zhang M.,
   2. Lute S.,
   3. Norling L.,
   4. Hong C.,
   5. Safta A.,
   6. O'Connor D.,
   7. Bernstein L. J.,
   8. Wang H.,
   9. Blank G.,
   10. Brorson K.,
   11. Chen Q.

   A novel, Q-PCR based approach to measuring endogenous retroviral clearance by capture protein A chromatography. Biotechnol. Bioeng. 2009, 102 (5), 1438–1347.

   OpenUrlPubMed